BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 24559644)

  • 1. MAPT IVS1+124 C>G modifies risk of LRRK2 G2385R for Parkinson's disease in Chinese individuals.
    Dan X; Wang C; Ma J; Feng X; Wang T; Zheng Z; Chan P
    Neurobiol Aging; 2014 Jul; 35(7):1780.e7-1780.e10. PubMed ID: 24559644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do interactions between SNCA, MAPT, and LRRK2 genes contribute to Parkinson's disease susceptibility?
    Biernacka JM; Armasu SM; Cunningham JM; Ahlskog JE; Chung SJ; Maraganore DM
    Parkinsonism Relat Disord; 2011 Dec; 17(10):730-6. PubMed ID: 21816655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants.
    Heckman MG; Elbaz A; Soto-Ortolaza AI; Serie DJ; Aasly JO; Annesi G; Auburger G; Bacon JA; Boczarska-Jedynak M; Bozi M; Brighina L; Chartier-Harlin MC; Dardiotis E; Destée A; Ferrarese C; Ferraris A; Fiske B; Gispert S; Hadjigeorgiou GM; Hattori N; Ioannidis JP; Jasinska-Myga B; Jeon BS; Kim YJ; Klein C; Kruger R; Kyratzi E; Lin CH; Lohmann K; Loriot MA; Lynch T; Mellick GD; Mutez E; Opala G; Park SS; Petrucci S; Quattrone A; Sharma M; Silburn PA; Sohn YH; Stefanis L; Tadic V; Tomiyama H; Uitti RJ; Valente EM; Vassilatis DK; Vilariño-Güell C; White LR; Wirdefeldt K; Wszolek ZK; Wu RM; Xiromerisiou G; Maraganore DM; Farrer MJ; Ross OA;
    Neurobiol Aging; 2014 Jan; 35(1):266.e5-14. PubMed ID: 23962496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study.
    Ross OA; Soto-Ortolaza AI; Heckman MG; Aasly JO; Abahuni N; Annesi G; Bacon JA; Bardien S; Bozi M; Brice A; Brighina L; Van Broeckhoven C; Carr J; Chartier-Harlin MC; Dardiotis E; Dickson DW; Diehl NN; Elbaz A; Ferrarese C; Ferraris A; Fiske B; Gibson JM; Gibson R; Hadjigeorgiou GM; Hattori N; Ioannidis JP; Jasinska-Myga B; Jeon BS; Kim YJ; Klein C; Kruger R; Kyratzi E; Lesage S; Lin CH; Lynch T; Maraganore DM; Mellick GD; Mutez E; Nilsson C; Opala G; Park SS; Puschmann A; Quattrone A; Sharma M; Silburn PA; Sohn YH; Stefanis L; Tadic V; Theuns J; Tomiyama H; Uitti RJ; Valente EM; van de Loo S; Vassilatis DK; Vilariño-Güell C; White LR; Wirdefeldt K; Wszolek ZK; Wu RM; Farrer MJ;
    Lancet Neurol; 2011 Oct; 10(10):898-908. PubMed ID: 21885347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between LRRK2 gene G2385R polymorphisms and Parkinson's disease.
    Yan H; Ma Q; Yang X; Wang Y; Yao Y; Li H
    Mol Med Rep; 2012 Oct; 6(4):879-83. PubMed ID: 22842796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of risk factor variants of LRRK2, MAPT, SNCA and TCEANC2 genes in Hungarian sporadic Parkinson's disease patients.
    Boros FA; Török R; Vágvölgyi-Sümegi E; Pesei ZG; Klivényi P; Vécsei L
    Neurosci Lett; 2019 Jul; 706():140-145. PubMed ID: 31085292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The age at motor symptoms onset in LRRK2-associated Parkinson's disease is affected by a variation in the MAPT locus: a possible interaction.
    Gan-Or Z; Bar-Shira A; Mirelman A; Gurevich T; Giladi N; Orr-Urtreger A
    J Mol Neurosci; 2012 Mar; 46(3):541-4. PubMed ID: 21898123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain-derived neurotrophic factor (BDNF) genetic polymorphism greatly increases risk of leucine-rich repeat kinase 2 (LRRK2) for Parkinson's disease.
    Liu J; Zhou Y; Wang C; Wang T; Zheng Z; Chan P
    Parkinsonism Relat Disord; 2012 Feb; 18(2):140-3. PubMed ID: 21924942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polygenic determinants of Parkinson's disease in a Chinese population.
    Guo JF; Li K; Yu RL; Sun QY; Wang L; Yao LY; Hu YC; Lv ZY; Luo LZ; Shen L; Jiang H; Yan XX; Pan Q; Xia K; Tang BS
    Neurobiol Aging; 2015 Apr; 36(4):1765.e1-1765.e6. PubMed ID: 25623333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The LRRK2 G2385R variant is a risk factor for sporadic Parkinson's disease in the Korean population.
    Kim JM; Lee JY; Kim HJ; Kim JS; Shin ES; Cho JH; Park SS; Jeon BS
    Parkinsonism Relat Disord; 2010 Feb; 16(2):85-8. PubMed ID: 19854095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An association analysis of the R1628P and G2385R polymorphisms of the LRRK2 gene in multiple system atrophy in a Chinese population.
    Yuan X; Chen Y; Cao B; Zhao B; Wei Q; Guo X; Yang Y; Yuan L; Shang H
    Parkinsonism Relat Disord; 2015 Feb; 21(2):147-9. PubMed ID: 25511328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatigue correlates with LRRK2 G2385R variant in Chinese Parkinson's disease patients.
    Fu R; Cui SS; Du JJ; He YC; Gao C; Huang P; Qian YW; Luo XG; Chen SD
    Parkinsonism Relat Disord; 2017 Nov; 44():101-105. PubMed ID: 28941828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LRRK2 G2385R and R1628P mutations are associated with an increased risk of Parkinson's disease in the Malaysian population.
    Gopalai AA; Lim SY; Chua JY; Tey S; Lim TT; Mohamed Ibrahim N; Tan AH; Eow GB; Abdul Aziz Z; Puvanarajah SD; Viswanathan S; Looi I; Lim SK; Tan LP; Chong YB; Tan CT; Zhao Y; Tan EK; Ahmad-Annuar A
    Biomed Res Int; 2014; 2014():867321. PubMed ID: 25243190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics of PD patients with LRRK2 G2385R and R1628P variants.
    Liang D; Shu L; Pan H; Xu Q; Guo J; Yan X; Tang B; Sun Q
    Neurosci Lett; 2018 Oct; 685():185-189. PubMed ID: 30121215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LRRK2 G2385R and LRRK2 R1628P increase risk of Parkinson's disease in a Han Chinese population from Southern Mainland China.
    Fu X; Zheng Y; Hong H; He Y; Zhou S; Guo C; Liu Y; Xian W; Zeng J; Li J; Liu Z; Chen L; Pei Z
    Parkinsonism Relat Disord; 2013 Mar; 19(3):397-8. PubMed ID: 22981185
    [No Abstract]   [Full Text] [Related]  

  • 16. Penetrance of LRRK2 G2385R and R1628P is modified by common PD-associated genetic variants.
    Wang C; Cai Y; Zheng Z; Tang BS; Xu Y; Wang T; Ma J; Chen SD; Langston JW; Tanner CM; Chan P;
    Parkinsonism Relat Disord; 2012 Sep; 18(8):958-63. PubMed ID: 22658533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between the LRRK2 G2385R variant and the risk of Parkinson's disease: a meta-analysis based on 23 case-control studies.
    Xie CL; Pan JL; Wang WW; Zhang Y; Zhang SF; Gan J; Liu ZG
    Neurol Sci; 2014 Oct; 35(10):1495-504. PubMed ID: 25027012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variants ofLRRK2 in Taiwanese Parkinson's disease.
    Wu YR; Chang KH; Chang WT; Hsiao YC; Hsu HC; Jiang PR; Chen YC; Chao CY; Chang YC; Lee BH; Hu FJ; Chen WL; Lee-Chen GJ; Chen CM
    PLoS One; 2013; 8(12):e82001. PubMed ID: 24339985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between G2385R and R1628P polymorphism of LRRK2 gene and sporadic Parkinson's disease in a Han-Chinese population in south-eastern China.
    Cai J; Lin Y; Chen W; Lin Q; Cai B; Wang N; Zheng W
    Neurol Sci; 2013 Nov; 34(11):2001-6. PubMed ID: 23624603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A common genetic factor for Parkinson disease in ethnic Chinese population in Taiwan.
    Fung HC; Chen CM; Hardy J; Singleton AB; Wu YR
    BMC Neurol; 2006 Dec; 6():47. PubMed ID: 17187665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.